Contained in this report is a review of available data on pituitary cytokines in domestic species of agricultural importance. The concept is advanced that the pituitary gland is essential to appropriate generation of host defense mechanisms and thus should be considered among other tissues contributing to innate immunity. The functions of these intrapituitary cytokines, principally IL-6, are discussed in the context of potential regulation of the pituitary-adrenal axis (ACTH secretion) via intrapituitary PGE2 generation during the acute-phase response to infectious/inflammatory stimuli. Data from other species are cited as appropriate for comparative purposes and elaboration of proposed mechanisms. However, the scope of the review is not intended to comprehensively cover the vast literature on proinflammatory cytokines and prostaglandins generated peripherally and centrally during host responses to inflammatory stimuli.

The aim of this study was to determine the ability of corticotropin-releasing hormone (CRH), lysine vasopressin (LVP), oxytocin (OT), and angiotensin II (AII) to stimulate adrenocorticotropin (ACTH) secretion from porcine anterior pituitary (AP) cells in vitro and to evaluate the role of protein kinase C (PKC) in the interaction between CRH and LVP. In this study, porcine AP cells were enzymatically and mechanically dispersed, cultured (150,000 cells/well) for 4 d, and then challenged with doses of various neuropeptides for 3 hr. CRH (10(-7)-10(-10) M) was the most potent of the peptides tested in stimulating ACTH release from porcine AP cells. In fact, none of the other peptides consistently affected ACTH concentrations relative to basal levels. However, LVP potentiated CRH action, even though by itself, it failed to stimulate ACTH production. Neither OT or AII potentiated CRH-stimulated ACTH release from porcine AP cells. To determine whether the inter-action between CRH and LVP was regulated partially by the protein Kinase C (PKC) pathway, we challenged AP cells in a 30-min incubation with 10(-7) M staurosporine (ST), a treatment predicted to decrease PKC activity. Then, cells were washed and challenged with 10(-9) M LVP, 10(-9) M CRH, and 10(-9) M CRH + LVP. Treatment with ST decreased (P < 0.05) CRH + LVP-stimulated ACTH release. To further demonstrate an interaction between protein kinase A (PKA) and PKC transduction pathways in the observed synergism between CRH and LVP to enhance ACTH secretion, we also challenged AP cells with 10(-7) M phorbol 12, 13-myristate acetate (PMA) and 5 microM forskolin (FOR) for 3 hr. This treatment was predicted to enhance PKA and PKC activities, respectively, and thereby enhance ACTH concentrations. Challenging cells with FOR + PMA enhanced (P < 0.001) ACTH release above basal concentrations, but more important, it increased (P < 0.001) ACTH concentration above that elicited by either drug given alone. Taken together, our in vitro studies support the conclusion that CRH is the principal regulator of ACTH secretion in the pig. In contrast to the results in most other species evaluated, vasopressin alone did not affect ACTH release. However, LVP can enhance the effectiveness of CRH in releasing ACTH, and this enhancement appears to rely, at least in part, on the activation of the PKC signal transduction pathway.

The pleiotropic cytokine interleukin-6 (IL-6) is produced in and secreted from anterior pituitary (AP) cells of a number of species. Bacterial endotoxin (END) may enhance the transcription of IL-6 and its secretion from the AP. In the studies presented here, we evaluated pig AP cells for the presence of IL-6 mRNA. In addition, because we had observed previously that END stimulated the secretion of prostaglandin E2 from cultured porcine AP cells, the effects of the inhibition of END-stimulated cyclooxygenase products on IL-6 mRNA abundance and the secretion of IL-6 were evaluated. In the first experiment, RNA was extracted from cultured pig AP cells that had been treated with END for 0.5 or 1 hr and subjected to reverse transcription followed by polymerase chain reaction and hybridization after Southern transfer. Bands of expected amplified product size, corresponding to IL-6, were observed only from cells treated with END, although specific hybridization was observed from both control and END-treated wells. In the next experiment, RNA was extracted from cultured AP cells treated with END or END in the presence of the cyclooxygenase inhibitor indomethacin (IND). Amplification of the expected product could be observed from all cultured cells except those treated with IND. However, hybridization data indicated that IND did not eliminate IL-6 mRNA entirely. Next, we measured IL-6 secretion from cultured AP cells exposed to END or END and IND. Treatment with END stimulated IL-6 secretion (P < 0.001) above controls, whereas IND blocked END stimulation of IL-6 secretion (P < 0.001). Finally, using immunostaining, we confirmed the presence of CD14, an END receptor, in cultured pig AP cells. These studies clearly establish the presence of IL-6 mRNA and secretion of the cytokine from cultured porcine AP cells. In addition, END stimulates the secretion of IL-6, perhaps through cells expressing CD14, and END-stimulated IL-6 secretion appears to be mediated by products of the cyclooxygenase pathway.